Moderna and Merck Develop Vaccine Cutting Risks of Skin Cancer

Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

More In Science

CDC Urges Increased Vaccine Coverage

The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.

W.H.O. Urges Ban on Flavored Vapes

The World Health Organization has warned that all E-cigarettes should be treated like tobacco and all flavored vapes should be banned.

Trial: Moderna, Merck Vaccine Reduces Cancer Death Rates

Merck and Moderna's cancer vaccine reduces the risk of death by about half, according to mid-stage trial data released Thursday.

1500 Percent Increase in Poison Center Calls

1500 Percent Increase in Poison Center Calls

Be Well: Resistance Band Workout for Lower Body

Resistance Band Workout for Lower Body

Be Well: Breaking the Stigma Around Conversations on Sexual Health

Breaking the Stigma Around Conversations on Sexual Health

Be Well: Understanding Seasonal Affective Disorder

Understanding Seasonal Affective Disorder

Be Well: Five Power Foods for A Longer Life

Five Power Foods for A Longer Life

COP28 Ends With Deal to Transition Away From Fossil Fuels

The COP28 summit in Dubai ended earlier Wednesday with a deal to transition away from using fossil fuels.

Be Well: Resistance Band Core Workout Routine

Resistance Band Core Workout Routine

Load More